UK Markets closed

Medistim ASA (0OCD.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
219.52-0.48 (-0.22%)
At close: 05:47PM GMT
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3219.52
52-week low 3214.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 518.18M
Implied shares outstanding 6N/A
Float 816.77M
% held by insiders 114.98%
% held by institutions 176.26%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 33.00
Trailing annual dividend yield 31.36%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022


Profit margin 20.65%
Operating margin (ttm)25.95%

Management effectiveness

Return on assets (ttm)19.75%
Return on equity (ttm)32.19%

Income statement

Revenue (ttm)444.33M
Revenue per share (ttm)24.37
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)320.7M
EBITDA 125.69M
Net income avi to common (ttm)91.76M
Diluted EPS (ttm)3.84
Quarterly earnings growth (yoy)-3.10%

Balance sheet

Total cash (mrq)104.03M
Total cash per share (mrq)5.7
Total debt (mrq)21.2M
Total debt/equity (mrq)6.86
Current ratio (mrq)4.30
Book value per share (mrq)15.44

Cash flow statement

Operating cash flow (ttm)138.7M
Levered free cash flow (ttm)90.23M